Effects of Dapagliflozin on the Urinary Albumin-to-Creatinine Ratio in Patients with Type 2 Diabetes: A Predefined Analysis from the DECLARE-TIMI 58 Randomised, Placebo-Controlled Trial

Topics: 

Citation
Raz I et al. Diabetes Jun 2019; 68 (Supplement 1):244-OR.